Patent application number | Description | Published |
20080221356 | Processes for the synthesis of O-desmethylvenlafaxine - The present invention describes processes for the preparation of O-desmethylvenlafaxine and tridesmethylvenlafaxine, which may be used as an intermediate in preparing O-desmethylvenlafaxine. | 09-11-2008 |
20080234516 | Processes for preparing solid states of O-desmethylvenlafaxine succinate - Provided are processes for the preparation of amorphous O-desmethylvenlafaxine and for the preparation of crystalline forms I, II, III, and IV of O-desmethylvenlafaxine. | 09-25-2008 |
20080269270 | Triol form of rosuvastatin and synthesis of rosuvastatin - Provided is a rosuvastatin triol and its use as a reference standard for analysis of rosuvastatin. Also provided are methods for preparation of rosuvastatin. | 10-30-2008 |
20090062572 | Processes for the synthesis of O-desmethylvenlafaxine - The present invention describes processes for the preparation of O-desmethylvenlafaxine and the intermediates cyclohexylbenzylcyanide and tridesmethylvenlafaxine, which may be used as intermediates in preparing O-desmethylvenlafaxine. | 03-05-2009 |
20090069563 | Rosuvastatin intermediates and their preparation - Provided are processes and intermediates for preparation of rosuvastatin. | 03-12-2009 |
20090069601 | Processes for the synthesis of O-desmethylvenlafaxine - The present invention describes processes for the preparation of O-desmethylvenlafaxine and tridesmethylvenlafaxine, which may be used as an intermediate in preparing O-desmethylvenlafaxine. | 03-12-2009 |
20090099383 | Purification of rosuvatatin intermediate by thin film evaporation and chemical method - Provided are processes for the purification of a pure rosuvastatin intermediate by thin film evaporation and chemical method, and conversion of the intermediate to rosuvastatin or salts thereof. | 04-16-2009 |
20090123983 | Processes for preparing an intermediate of sitagliptin via enzymatic reduction - The invention provides enzymatic reduction processes for the preparation of 4-(2,4,5-trifluorophenyl)-3-hydroxybutanoate, particularly, (S)-methyl 4-(2,4,5-trifluorophenyl)-3-hydroxybutanoate, a key intermediate in the synthesis of Sitagliptin, and the (S)- and (R)-enantiomers of methyl 4-(2,4,5-trifluorophenyl)-3-hydroxybutanoate in high enantiomeric purity. | 05-14-2009 |
20090137846 | Processes for the synthesis of O-Desmethylvenlafaxine - The present invention describes processes for the preparation of O-desmethylvenlafaxine and tridesmethylvenlafaxine, which may be used as an intermediate in preparing O-desmethylvenlafaxine. | 05-28-2009 |
20090170948 | Crystal forms of O-desmethylvenlafaxine fumarate - Provided are crystalline forms of O-desmethylvenlafaxine fumarate, methods for their preparation, and pharmaceutical compositions thereof. | 07-02-2009 |
20090187026 | Diastereomeric purification of rosuvastatin - The invention relates to diastereomerically pure rosuvastatin and processes for preparing diastereomerically pure rosuvastatin and its intermediates. | 07-23-2009 |
20090192326 | Preparation of sitagliptin intermediate - Intermediate compounds in the synthesis of Sitagliptin, 3-amino-4-(2,4,5-trifluorophenyl)but-2-enoic acid alkyl ester, and amino protected-3-amino-4-(2,4,5-trifluorophenyl)but-2-enoic acid alkyl ester, and the stereoselective reduction of these compound to give Synthon I, or the amino-protected Synthon I, are provided. | 07-30-2009 |
20090215806 | Rosuvastatin calcium with a low salt content - Provided is rosuvastatin calcium with a low salt by product content and processes for preparing such rosuvastatin calcium. | 08-27-2009 |
20090240054 | Rosuvastatin calcium with a low salt content - Provided is rosuvastatin calcium with a low salt by product content and processes for preparing such rosuvastatin calcium. | 09-24-2009 |
20090292142 | Substantially pure O-desmethylvenlafaxine and processes for preparing it - Methods for preparing substantially pure O-desmethylvenlafaxine are described. | 11-26-2009 |
20090318728 | PROCESSES FOR PREPARING PRODRUGS OF GABAPENTIN AND INTERMEDIATES THEREOF - Gabapentin prodrugs and intermediates thereof are described. | 12-24-2009 |
20100004485 | GABAPENTIN ENACARBIL SALTS AND PROCESSES FOR THEIR PREPARATION - The preparation and use of calcium, barium, magnesium and copper salts of gabapentin enacarbil are described. | 01-07-2010 |
20100190812 | NILOTINIB HCL CRYSTALLINE FORMS - Crystalline forms of Nilotinib HCl are described. | 07-29-2010 |
20100197916 | DIASTEREOMERIC PURIFICATION OF ROSUVASTATIN - The invention relates to diastereomerically pure rosuvastatin and processes for preparing diastereomerically pure rosuvastatin and its intermediates. | 08-05-2010 |
20110112200 | SOLID STATES OF O-DESMETHYLVENLAFAXINE SALTS - The present invention provides crystalline and amorphous salts of O-desmethylvenlafaxine and processes for preparing said salts of O-desmethylvenlafaxine. The present invention further provides pharmaceutical compositions comprising said salts of O-desmethylvenlafaxine. | 05-12-2011 |
20130096304 | NILOTINIB HCL CRYSTALLINE FORMS - Crystalline forms of Nilotinib HCl are described. | 04-18-2013 |